Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
about
Cognitive assessments for the early diagnosis of dementia after strokeA window into the heterogeneity of human cerebrospinal fluid Aβ peptidesCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingMitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's diseaseMeditation as a therapeutic intervention for adults at risk for Alzheimer's disease - potential benefits and underlying mechanisms.Exploiting thermodynamic data to optimize the enantioseparation of underivatized amino acids in ligand exchange capillary electrophoresis.Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease.Relationship of dementia screening tests with biomarkers of Alzheimer's disease.Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults.Identifying and validating biomarkers for Alzheimer's disease.Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-studyUsing biomarkers to improve detection of Alzheimer's disease.CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease.Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.Discovering Alzheimer Genetic Biomarkers Using Bayesian Networks.Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain.A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.Effects of Charged Cholesterol Derivatives on Aβ40 Amyloid Formation.Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients.Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.Perispinal etanercept: a new therapeutic paradigm in neurology.Current therapies and new strategies for the management of Alzheimer's disease.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Oculo-visual changes and clinical considerations affecting older patients with dementia.Integrative biomarker discovery in neurodegenerative diseases.Biomarkers in Sporadic and Familial Alzheimer's Disease.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood.Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42The pivotal role of copper(II) in the enantiorecognition of tryptophan and histidine by gold nanoparticles.Can the retina be used to diagnose and plot the progression of Alzheimer's disease?Early diagnosis of Alzheimer's disease using infrared spectroscopy of isolated blood samples followed by multivariate analyses.Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18F-florbetapir binding in non-demented patients with major depressive disorder.
P2860
Q27010423-454A3875-9C74-4779-A07F-9F7AB3316C44Q27010785-7653A733-3204-45AF-B766-DE95D329C149Q27023758-718CFD20-E1F2-4C97-86AB-3F94B88442C8Q28076999-9FF33D03-77AD-413B-AD54-F14037875E6CQ28260038-C162FA98-F17B-42F5-B335-D45D5AACBE54Q30413222-91A27842-3660-46C8-A2D8-84B7F6FCE6E7Q30563736-3FED5B1C-33F0-4F4C-8045-A862FA6963BCQ30945416-582816CD-9FDF-4D36-B5CE-7D8A5E94D090Q31144959-FB0F61B4-BA02-4308-A054-C964C068BBCDQ34044474-29066685-89D2-4169-8F61-B54C4E8985BDQ34247824-D26364C3-F35C-485C-BCEF-5BFE61342583Q34275897-A08D90D2-F9A7-4085-A3C3-F0E882BFE1FAQ34468961-42443390-1496-4EA4-8987-23D1ABDB9E5DQ34728483-89FF121B-15DF-4520-8180-2D43AE1BF2AFQ34735142-92366AD3-32EB-421E-BF22-8F528AF18174Q35034827-4D13BD23-55DD-469E-8500-7FD828CE2418Q35533115-FAAF0E5D-DC4D-4528-86BB-DE58887439E6Q35906655-2EE12A39-ED82-47C0-96E3-22368F6DDCAAQ36015518-99C8110C-54B8-48FF-A404-17E6F0B8AC6CQ36031308-E14DD153-A8C1-4BA0-8645-BDDF96BB9D3CQ36200059-D85AF996-EB72-41D9-BA7B-DE367A07CF82Q36379547-112CCCB0-A2F5-4F2D-A978-9A71AB379CFCQ37054037-25D0D308-9995-48EA-A505-5DB2C3497B63Q37123119-E17A6B79-95AB-46A1-ABE8-4AA129D7E4F1Q37346081-5BCAD11B-BD88-4D72-B862-7EC12446EBE0Q37727199-B7DA4301-3904-4FBE-B0D9-E02A5353B010Q37762260-C0EF2B65-FBA0-4B79-A438-84373F857616Q37770005-36984E4E-1F7F-40F0-A993-C3240792F223Q38037157-53ACF331-279A-4363-A27F-F5C543E0BA6CQ38222874-6006D8C1-D8E2-46A3-AEFB-5BC1BA01270CQ38533327-4F66C5C9-FF0B-478F-AE04-388D2BC8B2A6Q38542025-CF37DE31-2B2B-44BA-ACEF-84D8A1BEA148Q38592041-5F9163FB-F493-43A2-B35E-38D3AD1715D8Q39181900-2720B019-B18E-4EDA-8FEA-0FF4504C4904Q42252548-CE48F809-B924-447A-B1D0-C2EE425C8141Q42682593-C7176117-2D7E-46BB-98B4-15541001AFB2Q46971493-71B8CFDA-AB7A-4332-9879-5393C5F2F8A8Q47315641-9A47BB38-64F9-45F4-A4ED-9644B63A3764Q47883557-D9876F50-D661-476C-BA32-AF3B55121740Q50050458-9299AF0A-EA37-4B27-A20A-F624365C45B3
P2860
Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@en
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@nl
type
label
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@en
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@nl
prefLabel
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@en
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@nl
P921
P1476
Biomarkers for Alzheimer's dis ...... imitations and future aspects.
@en
P356
10.1016/J.EXGER.2009.09.008
P577
2009-09-29T00:00:00Z